CASE REPORT: THROMBECTOMY COMPLICATION IN ACUTE MYOCARDIAL INFARCTION – TO ASPIRATE OR NOT TO ASPIRATE?
Main Article Content
Abstract
Introduction: Coronary artery thrombus occurs due to the rupture or erosion of a pre-existing atherosclerotic plaque within the coronary lumen. This is a common pathological finding in acute coronary syndrome (ACS), especially in ST-elevation myocardial infarction (STEMI). It has a substantial impact on the efficacy and outcomes of percutaneous coronary intervention (PCI), being a strong predictor of periprocedural complications, distal embolization, and stent thrombosis. Current guidelines from major cardiology societies such as the European Society of Cardiology (ESC), American College of Cardiology (ACC), and the Vietnam National Heart Association recommend against the routine use of manual thrombus aspiration in PCI for acute myocardial infarction due to its associated complications. This paper presents a clinical case of acute myocardial infarction with a serious complication related to thrombus aspiration and discusses the clinical implications and preventive strategies derived from this experience. Methods: A Case Report. Results: We report a case of acute ST-elevation myocardial infarction with a large thrombus burden identified on coronary angiography. Manual thrombus aspiration was performed, resulting in occlusion of non-culprit branches. This led to cardiogenic shock and cardiac arrest, followed by successful resuscitation. Based on this experience, we propose several preventive measures to mitigate the risks of thrombus aspiration in similar clinical scenarios. Conclusion: Routine thrombus aspiration is no longer recommended in acute coronary syndrome management due to the risk of serious complications, including embolization to non-culprit coronary arteries. It is crucial to consider alternative strategies tailored to the patient's risk profile to prevent adverse outcomes.
Article Details
Keywords
Myocardial infarction, acute coronary syndrome, thrombus aspiration, complications, cardiogenic shock
References
2. Fröbert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369(17): 1587-1597. doi:10.1056/ NEJMoa1308789
3. Gibson CM, de Lemos JA, Murphy SA, et al. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation. 2001;103(21): 2550-2554. doi:10. 1161/01.cir.103.21.2550.
4. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2): 119-177. doi:10.1093/ eurheartj/ehx393
5. Migliorini A, Stabile A, Rodriguez AE, et al. Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trial. J Am Coll Cardiol. 2010; 56(16): 1298-1306. doi:10.1016/j.jacc. 2010.06.011
6. Prospective, Randomized, Multicenter Evaluation of a Polyethylene Terephthalate Micronet Mesh-Covered Stent (MGuard) in ST-Segment Elevation Myocardial Infarction: The MASTER Trial - PubMed. Accessed February 24, 2023.
7. Sianos G, Papafaklis MI, Daemen J, et al. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol. 2007;50(7):573-583. doi:10.1016/j.jacc.2007.04.059
8. Thompson PL, Simes J, Eikelboom J. Tirofiban on top of clopidogrel in patients undergoing percutaneous coronary intervention: The TOTAL trial. European Heart Journal. 2018; 39(23):2023–2030.